Pear therapeutics announces process exploring strategic alternatives

Boston--(business wire)--pear therapeutics, inc. (nasdaq: pear) (“the company”), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (pdts), today announced that it is engaged in a process to explore strategic alternatives to maximize shareholder value. the company has engaged mts health partners, l.p. to act as the company's exclusive financial advisor to assist in evaluating potential alternatives. mts health partners is a leading boutique investment bank that provides strategic and financial advice to the healthcare industry.
PEAR Ratings Summary
PEAR Quant Ranking